Provided by Tiger Fintech (Singapore) Pte. Ltd.

Envoy Medical Inc.

1.48
+0.03002.07%
Post-market: 1.40-0.0800-5.41%16:29 EDT
Volume:26.82K
Turnover:39.77K
Market Cap:31.56M
PE:-1.08
High:1.51
Open:1.50
Low:1.42
Close:1.45
Loading ...

Envoy Medical Inc. Secures New Category III CPT Codes for Esteem® Implant, Effective July 1, Paving Way for Innovative Hearing Solutions

Reuters
·
Yesterday

Envoy Medical Inc - Appoints Robert Potashnick as Interim CFO - SEC Filing

THOMSON REUTERS
·
25 Jun

Envoy Medical Inc. Appoints Robert Potashnick as Interim Chief Financial Officer

Reuters
·
25 Jun

Director Mona Chetan Patel Reports Acquisition of Common Shares in Envoy Medical Inc

Reuters
·
11 Jun

Envoy Medical Inc. Announces Positive Progress in Pivotal Trial for Fully Implanted Acclaim® Cochlear Implant, Plans for Expansion and Commercialization

Reuters
·
10 Jun

Envoy Medical Inc. Conducted Annual Stockholders Meeting

Reuters
·
04 Jun

Envoy Medical Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
27 May

Envoy Medical Inc - Brent T. Lucas to Serve as Interim CFO - SEC Filing

THOMSON REUTERS
·
19 May

Envoy Medical Inc. Announces Departure of CFO David R. Wells, CEO Brent T. Lucas to Assume Interim Financial Officer Role

Reuters
·
19 May

Envoy Medical Reports on First Quarter 2025 Results

Newsfile
·
02 May

Envoy Medical Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
21 Apr

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Newsfile
·
31 Mar

Envoy Medical to Participate in the 37th Annual ROTH Conference

Newsfile
·
10 Mar

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Newsfile
·
24 Feb

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Newsfile
·
14 Feb

Envoy Medical Inc: May Offer and Sell Shares of Class a Common Stock of up to $15 Mln From Time to Time - SEC Filing

THOMSON REUTERS
·
21 Jan